| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 2,136 |
| Depreciation | 214 |
| Amortization | 45 |
| Share-based compensation expense | 458 |
| Accounts receivable | 96 |
| Contract assets | 134 |
| Inventories | 515 |
| Prepaid expenses and other assets | 241 |
| Income tax receivable, net | 202 |
| Accounts payable and accrued liabilities | 448 |
| Accrued compensation | -2,348 |
| Net cash provided by operating activities | 169 |
| Expenditures for property and equipment | 252 |
| Expenditures for finite-life intangible assets | 15 |
| Net cash used for investing activities | -267 |
| Issuance of common stock upon exercise of options | 156 |
| Taxes paid on net share settlement of stock awards | 229 |
| Repurchase of common stock | 1,003 |
| Net cash used for financing activities | -1,076 |
| Net decrease in cash | -1,174 |
| Cash and cash equivalents at beginning of period | 15,287 |
| Cash and cash equivalents at end of period | 14,113 |
Electromed, Inc. (ELMD)
Electromed, Inc. (ELMD)